Outcomes of Mastoid Obliteration Canal Wall Down Tympanomastoidectomy in Cholesteatoma Surgery

Randomised study to evaluate the outcomes of mastoid cavity obliteration by muscle versus bone in canal wall down tympanomastoidectomy in cholesteatoma surgery

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Cholesteatoma Keratosis Skin Diseases Skin and Connective Tissue Diseases

Age range

5 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Assiut university hospital, Asyut, Egypt

About this study

Regarding discharge Time of epithelizqtion Hearing outcomes Quality of life

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

all patients who have extensive or recuutrent cholesteatoma undergoing canal wall down tympanomastoidectomy

Exclusion criteria

not willing for surgery
Malignancy

Patients with intracranial complication
Residual cholesteatoma

Treatment and study plan

Canal wall down tympanomastoidectomy

Procedure

Mastoid cavity obliteration by in canal wall down tympanomastoidectomy tympanomastoidectomy in cholesteatoma surgery

Primary outcomes

Size of mastoid cavity in mm

Time frame: 1 month

Endoscopic examination of the mastoid cavity after 1month to evaluate the degree of epithelization and if there is discharge .

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Important dates

Study start: 2023
Primary completion: 2028
Study completion: 2028
First posted: Feb 20, 2024
Registry last updated: Feb 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting